The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy	Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy	Recruiting	Phase 2	2026-08-05		NCT06599697

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CSI Pharmacy	1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	108
Octapharma USA, Inc.	2
University of Alabama at Birmingham	467

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins University	Baltimore	United States	49
University of Alabama at Birmingham	Birmingham	United States	193
University of Pittsburgh	Pittsburgh	United States	38
University of Texas Health Science Center at Houston	Houston	United States	42
University of Washington	Seattle	United States	172